Home>Bulk Products>N2-(tert-Butoxycarbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

DUNS: 560440352

BD117824[62062-43-5]N2-(tert-Butoxycarbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine*

Specific Information

Purity : 97% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :

Product Details

Cat No. : BD117824 Synonyms : N2-(tert-Butoxycarbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine
CAS No. : 62062-43-5 MDL NO : MFCD00133628
Formule : C21H36N4O6S InChI Key : N/A
M.W : 472.60 Pubchem ID : 16211301
Boiling Point : No data available

Safety

Signal Word : Warning Class :
Precautionary Statements : P261-P280-P301+P312-P302+P352-P305+P351+P338 UN# :
Hazard Statements : H302-H315-H319-H335 Packing Group :
GHS Pictogram:

R&D Center